Biostorage has expanded its sample management offerings to include laboratory sample preparation services, including sample aliquoting and nucleic acid extraction and verification.
The company's US and European facilities will now offer nucleic acid extraction and verification services in addition to sample aliquoting and PBMC (peripheral blood mononuclear cells) processing.
All services will be supported by automated liquid handling technology to ensure the accuracy and precision needed for high-throughput testing and screening.
The integration of these ancillary services allows Biostorage Technologies to provide customers with a sample renewal and extension process to maximise their samples for comprehensive research and development activities.
Once samples are processed, aliquots of blood and/or DNA products can be allocated for future testing by using informed sample prioritisation through the company's tracking and inventory management system, ISISS.
This process ensures samples are removed, transported, processed and replaced to storage in a compliant, consistent and efficient fashion.
'Errors that can affect the results of laboratory tests often occur in the pre-analytical phase,' said Cathy Michael, global head of sample management operations, Biostorage Technologies.
'By extending our technical expertise to sample preparation services, we can help to mitigate the risk of variables that have a negative impact on sample integrity,' she added.
Biostorage said it can now provide customers with improved control over the quality of samples that are shipped to central or referral laboratories for traditional clinical trial laboratory testing services.
The company stores and manages specimens from large biopharmaceutical companies and CROs.
Utilising ISISS, a sample security and web-based tracking tool, Biostorage also provides a complete FDA-compliant audit trail annotated on every sample.
